Cecilia T Skinner

Cecilia T. Skinner is a highly experienced project and program manager specializing in CMC and drug product manufacturing within the biopharmaceutical industry. Currently serving as a CMC Project Manager (Consultant) at CG Oncology, Cecilia oversees commercial GMP remediation and PPQ readiness activities across various CMO sites. Previously, as a Senior Program Manager at Novavax, Cecilia managed the CMC development of a co-formulated COVID-Influenza investigational vaccine and led drug product manufacturing programs for multiple vaccines. Cecilia's experience includes managing EUA approvals and CMC regulatory submissions at Argonaut Manufacturing Services Inc., and conducting audits and compliance at Ajinomoto Bio-Pharma Services. Cecilia holds a Master of Science in Drug Development and Product Management from UC San Diego and a Bachelor of Arts in International Studies - Economics.